Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avant Genomics is a private biotechnology and diagnostics company developing automated sample-preparation systems for liquid biopsy workflows in oncology. The company is focused on standardizing and simplifying a major bottleneck in precision cancer testing by automating front-end laboratory preparation for circulating tumor DNA analysis. Its lead platform, Avant Source, is designed to reduce manual handling, improve DNA yield, and enable more consistent and scalable liquid biopsy testing in clinical and research settings. Avant Genomics was spun out of the University of Virginia and is led by co-founders Rachelle Turiello and Renna Nouwairi in Charlottesville, Virginia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avant Genomics.